Author:
Trashkov Alexander P.,Gagloeva Tamara D.,Budko Alexander I.,Timaeva Olyesya I.,Kopaeva Marina Yu.,Cherepov Anton B.,Tsygan Nikolay V.,Stanzhevsky Andrei A.,Vasiliev Andrey G.,Pahomova Mariya A.,Maistrenko Dmitri N.,Sergunova Christina A.,Sysoev Dmitri S.,Shatic Sergei V.,Antuganov Dmitri O.,Konevega Andrei L.
Abstract
Biodistribution and kinetics were studied of potentially target biospecific radiopharmaceutical medication for the treatment of malignant tumors of various histologic type and location with expression of cytotoxic T-lymphocyte membrane associated glycoprotein 4 and glucocorticoid Induced Tumor Necrosis Factor Receptor) 177Lu-DOTA-anti-CTLA4-GITR. Colorectal cancer experimental model has been successfully reproduced by means of murine large intestine experimental adenocarcinoma cells (AKATOL) СТ26 EGFR) direct transplantation. The model was characteristic of moderate growth rate and practically complete absence of metastatic spread. Immunohistochemical assay of tumor tissue has revealed satisfactory expression level of target antigens for the medication under study, i.e. cytotoxic T-lymphocyte associated protein 4 (CTLA4) as well as membrane receptor of tumor necrosis factor group (GITR). This medication 177Lu-DOTA-anti-CTLA4-GITR has been shown to store in the tumor tissue. Its major pathways out of the organism were through urinary system. On the other hand, the medication has also been demonstrated to store in non-target tissues, namely: kidneys, liver, large intestine. The results of this study may be used in preclinical studies of medications and serve as a basis for broader studies of 177Lu-DOTA-anti-CTLA4-GITR and its safety.
Reference17 articles.
1. Tumor Microenvironment: A Key Contributor to Cancer Progression, Invasion, and Drug Resistance
2. Characterization of the tumor cell microenvironment
3. Molecular-genetic mechanisms of initiation, promotion and progression of tumors
4. Belozertseva IV, Blinov DV, Krasil’shchikova MS, editors. Rukovodstvo po soderzhaniyu i ispol’zovaniyu laboratornykh zhivotnykh. 8-e edition. Moscow: IRBIS, 2017. 336 p. (In Russ.)
5. Kaprin AD, Starinskii VV, Shakhzadova AO, editors. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2021 godu. Moscow: MNIOI im. P.A. Gertsena — filial FGBU “NMITS radiologiI” Minzdrava Rossii, 2022. 239 p. (In Russ.)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献